日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Therapeutic reprogramming of tumour-associated macrophages in pancreatic cancer using a cytotoxic CCR2-targeted nanotheranostic

利用靶向CCR2的细胞毒性纳米诊疗剂对胰腺癌肿瘤相关巨噬细胞进行治疗性重编程

Somani, Vikas Kumar; Zhang, Xiaohui; Chen, Timothy Hung-Po; Bulle, Ashenafi; Bansod, Sapana; Li, Lin; Geng, Yutong; Kang, Liang-I; Heo, Gyu Seong; Luehmann, Hannah; Zhang, Yuena; Saeed, Muhammad A; Lavine, Kory J; DeNardo, David G; Pachynski, Russell K; Liu, Yongjian; Lim, Kian-Huat

Phase 2 trial of pTVG-HP ± pTVG-AR DNA vaccines and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)

pTVG-HP ± pTVG-AR DNA 疫苗和帕博利珠单抗治疗转移性去势抵抗性前列腺癌 (mCRPC) 患者的 II 期试验

Kyriakopoulos, Christos E; Pachynski, Russell K; Eickhoff, Jens C; Tonelli, Tommaso P; Jeon, Donghwan; McNeel, Douglas G

Modeling Time-Dependent Recovery to Improve Esophagitis Prediction in Thoracic Reirradiation

利用时间依赖性恢复模型改进胸部再放射治疗后食管炎的预测

de Sousa, Cecilia F P M; Doss, Victoria L; Hales, Elaina; Yu, Kaichen; Trent, Tinker; Hagan, Esi; Gebre, Tsion; Obaideen, Anas; Negassa, Meti; Liu, Dezhi; Hu, Chen; Viswanathan, Akila N; Li, Heng; Voong, K Ranh; Jia, Xun; Hales, Russell K; McNutt, Todd R; Ger, Rachel B

Prescription Monitoring Program Mandates and Opioids Dispensed to Patients Dying of Cancer

处方监测计划的要求以及向癌症临终患者发放的阿片类药物

Bao, Yuhua; Zhang, Hao; Pinheiro, Laura C; Hu, Ju-Chen; Portenoy, Russell K; Bruera, Eduardo; Reid, M Carrington; Tamimi, Rulla M; Zhang, Fang; Zhang, Yiye; Paice, Judith A; Rosa, William E

PIEZO1 Channels Modulate the Small Extracellular Vesicle Release in C2C12 Cells

PIEZO1通道调节C2C12细胞中小细胞外囊泡的释放

Annalisa, Bernareggi; Ru, Zhang Wen; Laura, Sanchez-Sanchez; Alessia, Norbedo; Anna, Fracassi; Marianna, Lucafò; Marina, Sciancalepore; Griffoni, Alberto; William, Russell K; Giulio, Taglialatela; Paola, Lorenzon; Agenor, Limon

A study within a trial evaluating supplemental, reinforced risk-based training to reduce implementation barriers in a pediatric multicenter randomized controlled trial

一项在儿科多中心随机对照试验中开展的研究,旨在评估补充性的、强化型的基于风险的培训,以减少实施障碍。

Green, Danielle J; Vasenina, Valeriya; Meyerhoffer, Kelsee; Banks, Russell K; Hall, Mark W; Zuppa, Athena F; Watt, Kevin M; Dilts, Natalie; VanBuren, John M

Assessing Surgical Capacity in Guam: Current Strengths and Future Goals

评估关岛的外科手术能力:当前优势和未来目标

Benavente, Ryan V; Biala, Eduardo B Jr; Lopez, Brandon A; Gimmen, Megan Y; Pineda, Eric T; Narvaez, John Reinier F; Woo, Russell K; Palafox, Neal A; Buenconsejo-Lum, Lee E

Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses

围手术期应用纳武利尤单抗或纳武利尤单抗联合伊匹木单抗治疗可切除的弥漫性胸膜间皮瘤:一项 2 期试验和 ctDNA 分析

Reuss, Joshua E; Lee, Paul K; Mehran, Reza J; Hu, Chen; Ke, Suqi; Jamali, Amna; Najjar, Mimi; Niknafs, Noushin; Wehr, Jaime; Oner, Ezgi; Meng, Qiong; Pereira, Gavin; Hosseini-Nami, Samira; Sausen, Mark; Zahurak, Marianna; Battafarano, Richard J; Hales, Russell K; Friedberg, Joseph; Sepesi, Boris; Deutsch, Julie S; Cottrell, Tricia; Taube, Janis; Illei, Peter B; Smith, Kellie N; Pardoll, Drew M; Tsao, Anne S; Brahmer, Julie R; Anagnostou, Valsamo; Forde, Patrick M

Computational design of highly signalling-active membrane receptors through solvent-mediated allosteric networks

通过溶剂介导的变构网络进行高信号活性膜受体的计算设计

K-Y M Chen # ,J K Lai # ,L S P Rudden # ,J Wang ,A M Russell ,K Conners ,M E Rutter ,B Condon ,F Tung ,L Kodandapani ,B Chau ,X Zhao ,J Benach ,K Baker ,E J Hembre ,P Barth

Synergistic potential of sipuleucel-T in enhancing immunotherapy for metastatic castration-resistant prostate cancer

sipuleucel-T 在增强转移性去势抵抗性前列腺癌免疫治疗中的协同潜力

Rawat, Kavita; Punia, Varnika; Mathews, Parker; McCoy, Sara; Song, Wilbur; Saeed, Muhammad A; Pachynski, Russell K